Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trisha M Wise-Draper

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Pathology, Research and Practice|August 1, 2024
Multimodal assessment of high-risk human papillomavirus in sinonasal squamous cell carcinomaAnna Zhou, Anish Sharma, Damaris Kuhnell, et al.
Head & Neck|October 22, 2022
Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detectionChenna R Galiveti, Damaris Kuhnell, Jacek Biesiada, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2022
Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozoleAniruddha S Karve, Janki M Desai, Nimita Dave, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2013
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancerEl Mustapha Bahassi, Ya-Qin Li, Trisha M Wise-Draper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2024
A First-in-Human Phase I Study of BXQ-350, a First-in-Class Sphingolipid Metabolism Regulator, in Patients with Advanced/Recurrent Solid Tumors or High-Grade GliomasOlivier Rixe, John L Villano, Robert Wesolowski, et al.
Cancer Letters|January 15, 2021
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma modelsChristina A Wicker, Brian G Hunt, Sunil Krishnan, et al.
Cancer Research|February 19, 2009
Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivoTrisha M Wise-Draper, Rachael A Mintz-Cole, Teresa A Morris, et al.
Cancer Medicine|July 11, 2020
COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspectiveMichelle Marcum, Nicky Kurtzweil, Christine Vollmer, et al.
Viruses|April 26, 2025
A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck CancersMary C Bedard, Cosette M Rivera-Cruz, Tafadzwa Chihanga, et al.
Head & Neck|March 26, 2018
Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinomaSulsal-Ul Haque, Liang Niu, Damaris Kuhnell, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Pathology, Research and Practice|August 1, 2024
Multimodal assessment of high-risk human papillomavirus in sinonasal squamous cell carcinomaAnna Zhou, Anish Sharma, Damaris Kuhnell, et al.
Head & Neck|October 22, 2022
Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detectionChenna R Galiveti, Damaris Kuhnell, Jacek Biesiada, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2022
Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozoleAniruddha S Karve, Janki M Desai, Nimita Dave, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2013
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancerEl Mustapha Bahassi, Ya-Qin Li, Trisha M Wise-Draper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2024
A First-in-Human Phase I Study of BXQ-350, a First-in-Class Sphingolipid Metabolism Regulator, in Patients with Advanced/Recurrent Solid Tumors or High-Grade GliomasOlivier Rixe, John L Villano, Robert Wesolowski, et al.
Cancer Letters|January 15, 2021
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma modelsChristina A Wicker, Brian G Hunt, Sunil Krishnan, et al.
Cancer Research|February 19, 2009
Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivoTrisha M Wise-Draper, Rachael A Mintz-Cole, Teresa A Morris, et al.
Cancer Medicine|July 11, 2020
COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspectiveMichelle Marcum, Nicky Kurtzweil, Christine Vollmer, et al.
Viruses|April 26, 2025
A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck CancersMary C Bedard, Cosette M Rivera-Cruz, Tafadzwa Chihanga, et al.
Head & Neck|March 26, 2018
Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinomaSulsal-Ul Haque, Liang Niu, Damaris Kuhnell, et al.
Pageof 8